EMERGENT BIOSOLUTIONS INC. Goodwill, Gross
EMERGENT BIOSOLUTIONS INC. (EBS) had Goodwill, Gross of $224.90 million as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillGross · last filed 2022-02-25
- 2021-12-31: Goodwill, Gross $224.90M.
- 2020-12-31: Goodwill, Gross $266.70M.
- 2019-12-31: Goodwill, Gross $266.60M.
- 2019-09-30: Goodwill, Gross $268.60M.
| Period end | Goodwill, Gross | Goodwill, Gross as first filed |
|---|---|---|
| 2021-12-31 | $224.90M 10-K · filed 2022-02-25 | |
| 2020-12-31 | $266.70M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $266.60M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $268.60M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $268.30M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $267.70M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $259.70M 10-K · filed 2021-02-19 | $259.70K 10-K · filed 2019-02-22 |
| 2017-12-31 | $49.10M 10-K · filed 2020-02-25 | $49.13M 10-K · filed 2018-02-23 |
| 2016-12-31 | $41.00K 10-K · filed 2019-02-22 | $41.00M 10-K · filed 2017-02-28 |
| 2015-12-31 | $41.00M 10-K · filed 2017-02-28 | $54.90M 10-K · filed 2016-02-29 |
| 2015-09-30 | $52.59M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $52.59M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $41.98M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $52.59M 10-K · filed 2016-02-29 | $41.98M 10-K · filed 2015-03-09 |
| 2014-09-30 | $41.30M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $47.19M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $47.19M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $13.95M 10-K · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |